PL361334A1 - Optycznie czyste analogi kamptotecyny - Google Patents

Optycznie czyste analogi kamptotecyny

Info

Publication number
PL361334A1
PL361334A1 PL36133400A PL36133400A PL361334A1 PL 361334 A1 PL361334 A1 PL 361334A1 PL 36133400 A PL36133400 A PL 36133400A PL 36133400 A PL36133400 A PL 36133400A PL 361334 A1 PL361334 A1 PL 361334A1
Authority
PL
Poland
Prior art keywords
optically pure
camptothecin analogues
pure camptothecin
analogues
optically
Prior art date
Application number
PL36133400A
Other languages
English (en)
Other versions
PL202393B1 (pl
Inventor
Olivier Lavergne
Dennis Bigg
Christophe Lanco
Alain Rolland
Original Assignee
Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) filed Critical Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.)
Publication of PL361334A1 publication Critical patent/PL361334A1/pl
Publication of PL202393B1 publication Critical patent/PL202393B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL361334A 1999-02-26 2000-02-24 Analogi kamptotecyny, kompozycja farmaceutyczna je zawierająca i zastosowanie PL202393B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9902398A FR2790261B1 (fr) 1999-02-26 1999-02-26 Nouveaux analogues optiquement purs de la camptothecine et leurs procedes de preparation
PCT/FR2000/000461 WO2000050427A1 (fr) 1999-02-26 2000-02-24 Analogues optiquement purs de la camptothecine

Publications (2)

Publication Number Publication Date
PL361334A1 true PL361334A1 (pl) 2004-10-04
PL202393B1 PL202393B1 (pl) 2009-06-30

Family

ID=9542564

Family Applications (1)

Application Number Title Priority Date Filing Date
PL361334A PL202393B1 (pl) 1999-02-26 2000-02-24 Analogi kamptotecyny, kompozycja farmaceutyczna je zawierająca i zastosowanie

Country Status (29)

Country Link
US (1) US7012079B1 (pl)
EP (2) EP1338599B1 (pl)
JP (1) JP2002537399A (pl)
KR (1) KR20010108270A (pl)
CN (1) CN1195757C (pl)
AR (1) AR022740A1 (pl)
AT (2) ATE353902T1 (pl)
AU (1) AU772632B2 (pl)
BR (1) BR0008526A (pl)
CA (1) CA2364705C (pl)
CZ (1) CZ20013091A3 (pl)
DE (2) DE60003170T2 (pl)
DK (1) DK1165565T3 (pl)
ES (2) ES2200829T3 (pl)
FR (1) FR2790261B1 (pl)
HK (1) HK1045514B (pl)
HR (1) HRP20010622A2 (pl)
HU (1) HUP0200529A3 (pl)
IL (2) IL144987A0 (pl)
MX (1) MXPA01008658A (pl)
MY (1) MY127819A (pl)
NO (1) NO327260B1 (pl)
NZ (1) NZ514153A (pl)
PL (1) PL202393B1 (pl)
PT (1) PT1165565E (pl)
RU (1) RU2230745C2 (pl)
TW (1) TWI268931B (pl)
WO (1) WO2000050427A1 (pl)
ZA (1) ZA200107738B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207832B1 (en) 1999-04-09 2001-03-27 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
US6372906B1 (en) 2001-04-12 2002-04-16 University Of Pittsburgh Synthesis of silyl camptothecins and silyl homocamptothecins
US6723853B2 (en) 2001-08-27 2004-04-20 University Of Pittsburgh Intermediates and methods of preparation of intermediates in the enantiomeric synthesis of (20R)homocamptothecins and the enantiomeric synthesis of (20R)homocamptothecins
AR046579A1 (es) * 2003-11-12 2005-12-14 Smithkline Beecham Corp Compuesto cristalino de topotecan, composicion farmaceutica que lo comprende, procedimiento para prepararlo y su uso para preparar dicha composicion farmaceutica
CN100408582C (zh) * 2004-02-12 2008-08-06 中国人民解放军第二军医大学 高喜树碱类化合物及其制备方法和用途
JP2008513437A (ja) 2004-09-21 2008-05-01 ソシエテ ド コンセイユ ド ルシェルシェ エ ダアップリカーション シャンティフィック（エス．セー．エール．アー．エス．） 有用な中間体の新規製造方法
US8575484B1 (en) 2010-09-14 2013-11-05 Cooper Technologies Company Adjustable-depth ring assembly and method of installation
WO2025255212A1 (en) * 2024-06-07 2025-12-11 Codeable Therapeutics, Incorporated Topoisomerase inhibitors, antibody-drug conjugates comprising them, and methods of their use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3008226B2 (ja) * 1991-01-16 2000-02-14 第一製薬株式会社 六環性化合物
FR2757515B1 (fr) * 1996-12-20 2000-05-05 Sod Conseils Rech Applic Formes prodrogues et nouveaux analogues de la camptothecine, leurs procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
FR2757514B1 (fr) * 1996-12-20 1999-02-12 Sod Conseils Rech Applic Nouveaux analogues de la camptothecine, des procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
MX9710228A (es) * 1995-06-21 1998-03-31 Sod Conseils Rech Applic Nuevos analogos de camptotecina, procedimientos de preparacion, su aplicacion como medicinas y las composiciones farmaceuticas que los comprenden.
GB9512670D0 (en) * 1995-06-21 1995-08-23 Sod Conseils Rech Applic Camptothecin analogues
FR2768431B1 (fr) * 1997-08-29 2000-03-24 Sod Conseils Rech Applic Nouveaux analogues optiquement purs de la camptothecine, nouvel intermediaire de synthese optiquement pur et son procede de preparation
IL127800A (en) * 1996-08-19 2005-11-20 Bionumerik Pharmaceuticals Inc Highly lipophilic 7-substituted camptothecin derivatives and pharmaceutical compositions containing them
UA57757C2 (uk) * 1996-12-20 2003-07-15 Сос'Єте Де Консей Де Решерш Е Даплікасьон С'Єнтіфік (С.К.Р.А.С.) Аналоги камптотецину, спосіб їх отримання (варіанти) і фармацевтична композиція
AU6272598A (en) 1997-02-14 1998-09-08 Bionumerik Pharmaceuticals, Inc. Highly lipophilic camptothecin derivatives
US6207673B1 (en) * 1997-03-12 2001-03-27 The University Of North Carolina At Chapel Hill Covalent conjugates of topoisomerase I and topoisomerase II inhibitors
US6207832B1 (en) * 1999-04-09 2001-03-27 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof

Also Published As

Publication number Publication date
JP2002537399A (ja) 2002-11-05
TWI268931B (en) 2006-12-21
CN1195757C (zh) 2005-04-06
EP1338599A1 (fr) 2003-08-27
ATE242248T1 (de) 2003-06-15
IL144987A0 (en) 2002-06-30
CA2364705A1 (fr) 2000-08-31
PT1165565E (pt) 2003-10-31
KR20010108270A (ko) 2001-12-07
PL202393B1 (pl) 2009-06-30
MY127819A (en) 2006-12-29
DE60003170D1 (en) 2003-07-10
WO2000050427A1 (fr) 2000-08-31
HK1045514B (zh) 2005-11-18
CA2364705C (fr) 2010-03-30
IL144987A (en) 2006-12-31
EP1165565B1 (fr) 2003-06-04
CN1345321A (zh) 2002-04-17
HUP0200529A3 (en) 2004-03-29
NO327260B1 (no) 2009-05-25
AU772632B2 (en) 2004-05-06
BR0008526A (pt) 2002-01-08
US7012079B1 (en) 2006-03-14
ATE353902T1 (de) 2007-03-15
AU2921000A (en) 2000-09-14
EP1165565A1 (fr) 2002-01-02
ZA200107738B (en) 2003-02-26
EP1338599B1 (fr) 2007-02-14
HRP20010622A2 (en) 2002-08-31
ES2282564T3 (es) 2007-10-16
DE60033447T2 (de) 2007-10-31
DE60033447D1 (de) 2007-03-29
FR2790261A1 (fr) 2000-09-01
MXPA01008658A (es) 2002-03-14
NO20014117L (no) 2001-10-11
CZ20013091A3 (cs) 2002-05-15
DE60003170T2 (de) 2004-04-01
HK1045514A1 (en) 2002-11-29
FR2790261B1 (fr) 2004-09-10
NO20014117D0 (no) 2001-08-24
HUP0200529A2 (en) 2002-06-29
AR022740A1 (es) 2002-09-04
NZ514153A (en) 2001-09-28
DK1165565T3 (da) 2003-10-06
RU2230745C2 (ru) 2004-06-20
ES2200829T3 (es) 2004-03-16

Similar Documents

Publication Publication Date Title
HUP0202812A3 (en) Novel bicyclonucleoside analogues
GB0012650D0 (en) Light-emitting structure
IL186608A0 (en) Igf-like insulin variant
GB9923894D0 (en) Accelerometer
IL150371A0 (en) Navigation
PL355432A1 (pl) Analogi witaminy D
IL144987A0 (en) Optically pure camptothecin analogues
GB9928607D0 (en) Syringes
GB2346734B (en) Optical interface arrangement
GB0030217D0 (en) Structure
AU140253S (en) Protractor
GB9926080D0 (en) Structure
AU6550800A (en) Hepoxilin analogs
GB9903112D0 (en) Optical components
GB9903377D0 (en) Amphibious-tricycle (amphi-trike)
GB2347639B (en) Footplate
GB2349232B (en) Visor
IL132254A0 (en) Fiber-optic gyro
GB9907541D0 (en) Diamond dentures
GB9918373D0 (en) Molliboard (floodbarrier)
IL128276A0 (en) Marble
PL110253U1 (en) Free-standing dust-basket
PL109888U1 (en) Stop-watch
TW420096U (en) Ornaments structure improvement
AUPQ450799A0 (en) Clothes-type peg

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20120224